Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, respiratory system disorder, respiratory tract neoplasm, uterine disorderRecruitingPhase 12026-08-05NCT07444814

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Whitehawk Therapeutics, Inc.2

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Fred Hutchinson Cancer CenterSeattleUnited States250
Hackensack University Medical Center - John Theurer Cancer CenterHackensackUnited States5
NEXT - Oncology - HoustonHoustonUnited States1
Next Oncology - AustinAustinUnited States6
NEXT Oncology - Virginia Cancer SpecialistsFairfaxUnited States4
Roswell Park Comprehensive Care CenterBuffaloUnited States1
St. Francis Medical Center (OSF Healthcare)PeoriaUnited States2
START - MidwestGrand RapidsUnited States5
START - San AntonioSan AntonioUnited States7
UCLA - Hematology/Oncology Clinical Research UnitLos AngelesUnited States1
University Hospital - Cleveland Medical CenterClevelandUnited States2
University of ArkansasLittle RockUnited States1